z-logo
open-access-imgOpen Access
Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali
Author(s) -
Panchali Roy Chowdhury,
Christian Meier,
Hewád Laraway,
Yuxiao Tang,
Abraham Hodgson,
Samba O. Sow,
Godwin Enwere,
Brian D. Plikaytis,
Prasad S. Kulkarni,
MariePierre Préziosi,
Matthias Niedrig
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ603
Subject(s) - medicine , immunogenicity , immunology , virology , pediatrics , antibody
Yellow fever (YF) is still a major public health problem in endemic regions of Africa and South America. In Africa, one of the main control strategies is routine vaccination within the Expanded Programme on Immunization (EPI). A new meningococcal A conjugate vaccine (PsA-TT) is about to be introduced in the EPI of countries in the African meningitis belt, and this study reports on the immunogenicity of the YF-17D vaccines in infants when administered concomitantly with measles vaccine and PsA-TT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom